from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0701/rplC

LFCtreatmentdescriptionclass of inhibitor

1.677

Amikacinug/mL Amikacintranslation

1.387

Cap5-10ug/mL Capreomycintranslation

1.937

Rox10-50 ug/mL Roxithromycintranslation

1.102

SM2-5 ug/mL Streptomycintranslation

1.861

Tet5-10 ug/mL Tetracyclinetranslation

-0.396

Rif0.2-5ug/mL Rifampicintranscription

0.013

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.585

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.892

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.669

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.901

Clofazimine10-13 ug/mL Clofaziminerespiration

0.132

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.500

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.539

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.280

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.169

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.879

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.375

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.228

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.560

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.200

KCN5-20 ug/mL Potassium cyaniderespiration

-1.261

NaN30.2-2 mM Sodium aziderespiration

0.337

Nigericin50 uM Nigericinrespiration

-1.020

TRC10-150 ug/mL Triclosanrespiration

-1.406

TRZ10-25 ug/mL Thioridazinerespiration

0.979

Valinomycin0.5-10 uM Valinomycinrespiration

0.300

ZnSO42 mM ZnSO4respiration

-0.334

menadione6-10 ug/mL Menadionerespiration

-0.196

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.458

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.116

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.469

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.023

NRP_1Non-replicating persistence stage 1dosRassociated

0.776

Amp0.2mg/mL AmpicillincellWall

0.497

Cephalexin20-100 ug/mL CephalexincellWall

0.452

Cerulenin0.32-5 ug/mL CerulenincellWall

0.714

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.350

EMB10-20 ug/mL EthambutolcellWall

0.076

Eta12-40 ug/mL EthionamidecellWall

0.477

INH0.2-0.4 ug/mL IsoniazidcellWall

0.278

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.110

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.304

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.594

BZA0.12 mg/mL BenzamidearomaticAmides

-0.040

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.198

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.206

H2O24 mM hydrogen peroxideDNAdamaging

1.085

Levo10 ug/mL LevofloxacinDNAdamaging

1.035

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.346

Novobiocin10 ug/mL NovobiocinDNAdamaging

1.069

Oflox5-10 ug/mL OfloxacinDNAdamaging

1.279

UVUV-irradiationDNAdamaging

-1.012

ARP41-4 ug/mL Antitubercular compound ARP4?

0.404

Antimycin12.5-50 ug/mL Antimycin A?

0.228

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.167

PA_110-50 ug/mL Antitubercular compound PA-1?

0.161

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.754

PA8240.2-2 ug/mL PA-824?

-1.021

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.309

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.230

Verapamil50 uM Verapamil?

0.206

mercaptoethanol2 mM 2-Mercaptoethanol?

0.459

methoxatin10-20 ug/mL Methoxatin?